A securities fraud class action has been filed against PROCEPT BioRobotics Corporation after revelations that the company used undisclosed bulk discounts to inflate handpiece sales, leading to a 48% stock decline. The lawsuit, filed by Hagens Berman Sobol Shapiro LLP, represents investors who purchased PROCEPT common stock between February 28, 2024 and February 25, 2026. The complaint alleges that PROCEPT incentivized customers to place bulk orders exceeding actual procedure demand, pulling forward sales and artificially boosting reported revenues. Investors learned the truth through a series of disclosures starting August 6, 2025, when handpiece sales missed estimates, culminating on February 25, 2026, when the company revealed cumulative excess customer inventory of over 10,000 units and a 30% sequential drop in U.S. handpiece sales. The lead plaintiff deadline is September 22, 2026.
Procept Biorobotics CorpSecurities fraud class action over undisclosed inventory issues and 48% stock decline.
